Meiji Holdings Co., Ltd. · TSE:2269
Meiji — Q3 FYE March 2020 Earnings Presentation
15 slides from Meiji's earnings presentation, Feb 6, 2020
Slide 1: Financial Results - Q1-Q3 of FYE March 2020
Financial Results - For the Q1-Q3 of FYE March 2020 - (From April 1, 2019 to December 31, 2019) February 6, 2020
Slide 2: Summary - Q1-Q3 FYE March 2020
Summary - Q1-Q3 FYE March 2020 (JPY bn) FYE March FYE March FYE March 2019 2020 Meiji HD (consolidated) vs. 2020 Q1-Q3 Q1-Q3 YoY Full-year Full-year Plan Results Results Change Plan +0.1% Net sales 950.6 951.1 +0.4 72.7% 1,309.0 +0.9% Operating income 79.6 80.3 +0.7 74.4% 108.0 Op. income margin 8.4
Slide 3: Food Summary - Q1-Q3 FYE March 2020
Food Summary - Q1-Q3 FYE March 2020 (JPY bn) FYE March FYE March FYE March 2019 2020 2020 Food Segment Q1-Q3 Q1-Q3 YoY vs. Full-year Full-year Change Plan Results Results Plan -0.8% Net sales 803.1 796.6 -6.5 73.1% 1,090.0 +0.3% Operating income 64.9 65.1 +0.2 72.4% 90.0 (JPY bn) YoY Change in Opera
Slide 4: Food Sales by Mainstay Products
Food Sales by Mainstay Products - Q1-Q3 FYE March 2020 (JPY bn) FYE March FYE March FYE March 2019 Q1-Q3 2020 Q1-Q3 vs. 2020 YoY Food Segment Full-year Results Results Change Plan Full-year Plan Yogurt 65.1 63.7 -2.2% 70.3% 90.6 Meiji Bulgaria Yogurt 60.6 58.2 -3.9% 73.9% 78.8 Functional yogurt 81.0
Slide 5: Food Analysis of Operating Income
Food Analysis of Operating Income - Q1-Q3 FYE March 2020 Food Fresh and Other (JPY bn) Processed Corporate Segment Fermented Confectionery Nutrition Overseas Domestic Food Expenses Food Segment Total Dairy Subsidiaries Q1-Q3 Op. Income – 64.9 34.1 7.0 14.8 11.3 1.0 3.4 -6.9 FYE March 2019 Due to inc
Slide 6: Pharma Summary - Q1-Q3 FYE March 2020
Pharma Summary - Q1-Q3 FYE March 2020 (JPY bn) FYE March FYE March FYE March 2020 Pharmaceutical 2019 2020 YoY vs. Full-year Segment Q1-Q3 Results Q1-Q3 Results Change H1 Plan Plan +4.8% Net sales 148.2 155.4 +7.1 70.5% 220.5 +3.0% Operating income 15.1 15.6 +0.4 84.4% 18.5 (JPY bn) YoY Change in Op
Slide 7: Pharma Sales by Mainstay Products
Pharma 医薬品 Sales by Mainstay Products - Q1-Q3 FYE March 2020 (JPY bn) FYE March FYE March FYE March 2019 2020 Pharmaceutical 2020 Q1- YoY vs. Segment Q1-Q3 Full-year Q3 Results Change Full-year Plan Results Plan Ethical pharmaceuticals (Japan) - non-consolidated information for Meiji Seika Pharma SY
Slide 8: Full-year Outlook - FYE March 2020 [No Change]
Full-year Outlook - FYE March 2020 [No Change] (JPY bn) FYE March FYE March 2019 2020 Meiji HD (consolidated) Results Full-year YoY Change Plan Net sales 1,254.3 1,309.0 +4.4% +54.6 Operating income 98.3 108.0 +9.8% +9.6 Op. income margin 7.8% 8.3% +0.4pt Net income attributable to shareholders of 6
Slide 9: Topic: Progress in restructuring milk business
Topic 1 Progress in restructuring milk business 1. Launching value added products Maintain Launched Meiji Oishii Milk Calcium* freshness Easy to open in September 2019 in Japan * Made of raw milk manufactured by Click world’s first method Launched Meiji Oishii Gyunyu 450 ml in January 2020 in Ch
Slide 10: Topic: Developing drugs for treatment of blood cancer
Topic 2 Developing drugs for treatment of blood cancer Pharmaceutical business in Japan Infectious disease/vaccine Drugs for blood cancer positioned as Growth area Generic drugs (Sales, CMO/CDMO) Core in Meiji’s pharma business Bio-pharmaceuticals Area Hematologists prescribe a large Drugs for c
Slide 11: Appendix
Appendix 11 | Feb. 6, 2020 | Copyright © Meiji Holdings Co., Ltd. All rights reserved.
Slide 12: Financial Position as of December 2019
Financial Position as of December 2019 Results (JPY bn) as of Dec. 2019 Change Main Factors for Change +4.9% - Notes and accounts receivable (+17.6) Current assets 442.1 +20.7 - Cash and deposits (+4.5) - Allowance for doubtful accounts (-1.1) +1.7% - Buildings and structures (net) (+16.9) - Machine
Slide 13: Yogurt and Chocolate Market Trends in Japan
Yogurt and Chocolate Market Trends in Japan YoY Change (JPY bn) 5.0% 386.3 400.4 384.9 373.6 0.0% Yogurt 346.8 348.4 -5.0% -10.0% FY3/19 FY3/20 1Q 2Q 3Q 4Q 1Q 2Q 3Q FY3/14 FY3/15 FY3/16 FY3/17 FY3/18 FY3/19 (JPY bn) YoY Change 10.0% 526.0 550.0 537.0 486.0 504.0 Chocolate 452.0 5.0% 0.0% -5.0% FY3/1
Slide 14: Market prices of main raw materials imported
Market prices of main raw materials imported (USD/MT) Nonfat Dry Milk (USD/MT) Cheese 3,500 5,500 5,000 3,000 4,500 2,500 4,000 2,000 3,500 1,500 3,000 1,000 2,500 (GBP/MT) Cocoa beans (Cent/Bushel) Sugar 2,500 25 2,000 20 1,500 15 1,000 10 500 5 14 | Feb. 6, 2020 | Copyright © Meiji Holdings Co., L
Slide 15: Information in this material is not intended to solicit sale or purchase of
Information in this material is not intended to solicit sale or purchase of shares in Meiji Holdings. Business forecasts and other forward-looking statements are based on information available at the time of the release of this presentation and reasonable assumptions made by the Company. Actual
Meiji Holdings — Q3 FYE March 2020 Earnings Presentation on 6ix